You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

BAY43-9006

Showing 26 - 50 of 1,296
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Sorafenib and/or Regorafenib in Liver Cancer Subsequent to

Terminated
  • Hepatocellular Carcinoma
  • Regorafenib (Stivarga, BAY73-4506)
  • Sorafenib (Nexavar, BAY43-9006)
  • Multiple Locations, Germany
    Many Locations
Aug 20, 2020

Advanced Malignant Tumor, BRAF Gene Mutation, Metastatic Malignant Tumor Trial in Houston (Crizotinib, Laboratory Biomarker

Completed
  • Advanced Malignant Neoplasm
  • +4 more
  • Houston, Texas
    M D Anderson Cancer Center
Jan 19, 2021

Kaposi's Sarcoma, HHV-8, KSHV Trial run by the NCI (BAY 43-9006)

Terminated
  • Kaposi's Sarcoma
  • +2 more
  • BAY 43-9006
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Dec 11, 2019

Tumors Trial run by the NCI (Bevacizumab, BAY 43-9006)

Completed
  • Neoplasms
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Dec 14, 2019

Differentiated Thyroid Cancer Which is Radioactive Iodine

Completed
  • Thyroid Neoplasms
  • Sorafenib (Nexavar, BAY43-9006)
  • Other Multikinase inhibitors
  • Birmingham, Alabama
  • +33 more
Jun 6, 2021

Advanced Cancer Trial in Houston (Bevacizumab, Sorafenib, Erlotinib)

Completed
  • Advanced Cancer
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Jun 27, 2020

Blastic Phase, Childhood Acute Promyelocytic Leukemia With PML-RARA, Childhood Chronic Myelogenous Leukemia, BCR-ABL1 Positive

Completed
Has Results
  • Blastic Phase
  • +9 more
  • Laboratory Biomarker Analysis
  • +2 more
  • Birmingham, Alabama
  • +24 more
Jan 13, 2021

Neurofibromatosis Type I, Plexiform Neurofibroma Trial in Birmingham, Bethesda (Nexavar (BAY 43-9006) (Sorafenib), Toxicity,

Completed
  • Neurofibromatosis Type I
  • Plexiform Neurofibroma
  • Nexavar (BAY 43-9006) (Sorafenib)
  • +5 more
  • Birmingham, Alabama
  • +1 more
Dec 11, 2019

Leukemia, Acute Myeloid Leukemia Trial in Houston (Selinexor, Sorafenib)

Completed
Has Results
  • Leukemia
  • Acute Myeloid Leukemia
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Mar 18, 2020

Liver Cancer Trial in Richmond (sorafenib tosylate, vorinostat)

Completed
  • Liver Cancer
  • Richmond, Virginia
  • +1 more
Aug 16, 2019

Leukemia, MDS Trial in Canada (cytarabine)

Completed
  • Leukemia
  • Myelodysplastic Syndromes
  • Halifax, Nova Scotia, Canada
  • +3 more
Apr 6, 2020

Hepatocellular Cancer Trial in Honolulu (Sorafenib, yttrium-90 radioembolization)

Withdrawn
  • Hepatocellular Cancer
  • Honolulu, Hawaii
    University of Hawaii
Nov 6, 2019

Carcinoma, Hepatocellular Trial in Worldwide (Refametinib (BAY86-9766), Sorafenib (BAY43-9006))

Completed
  • Carcinoma, Hepatocellular
  • Refametinib (BAY86-9766)
  • Sorafenib (BAY43-9006)
  • Louisville, Kentucky
  • +78 more
Apr 6, 2021

Leukemia Trial in Houston (Azacytidine, Sorafenib)

Completed
Has Results
  • Leukemia
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Jan 6, 2020

Metastatic Differentiated Thyroid Cancer, Metastatic Poorly Differentiated Thyroid Cancer, Metastatic Anaplastic Thyroid Cancer

Completed
Has Results
  • Metastatic Differentiated Thyroid Cancer
  • +3 more
  • Philadelphia, Pennsylvania
    University of Pennsylvania - Abramson Comprehensive Cancer Cente
Nov 13, 2019

Acute Myeloid Leukemia With FLT3/ITD Mutation, Acute Myeloid Leukemia With Inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11,

Active, not recruiting
Has Results
  • Acute Myeloid Leukemia With FLT3/ITD Mutation
  • +5 more
  • Biopsy
  • +7 more
  • Lewes, Delaware
  • +42 more
Mar 15, 2022

Prostate Cancer Trial in Canada (sorafenib tosylate)

Completed
  • Prostate Cancer
  • sorafenib tosylate
  • Calgary, Alberta, Canada
  • +6 more
Apr 7, 2020

Hepatocellular Carcinoma Trial in Xi'an (Sorafenib, TACE)

Unknown status
  • Hepatocellular Carcinoma
  • Xi'an, Shaanxi, China
    Xijing Hospital of Digestive Disease
Jul 31, 2019

Hepatocellular Carcinoma Trial in Xi'an (Sorafenib, TACE)

Unknown status
  • Hepatocellular Carcinoma
  • Xi'an, Shaanxi, China
    Xijing Hospital of digestive disease, Fourth Military Medical Un
Jul 31, 2019

Advanced Renal Cell Carcinoma, With Failure or Unsuitable on

Terminated
  • Carcinoma, Renal Cell
  • Sorafenib (Nexavar, BAY43-9006)
  • (no location specified)
Jun 2, 2019

Clear Cell Renal Cell Carcinoma, Recurrent Renal Cell Cancer, Stage IV Renal Cell Cancer Trial in Houston (procedure, drug,

Terminated
Has Results
  • Clear Cell Renal Cell Carcinoma
  • +2 more
  • therapeutic conventional surgery
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Oct 22, 2018

Childhood Hepatocellular Carcinoma, Childhood Malignant Liver Tumor, Fibrolamellar Carcinoma Trial in Worldwide (drug, other,

Recruiting
  • Childhood Hepatocellular Carcinoma
  • +4 more
  • Birmingham, Alabama
  • +201 more
Jan 30, 2023

Biology of Skin Neurofibromas in Neurofibromatosis Type 1

Completed
  • Neurofibromatosis Type 1
  • Neurofibroma
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jan 20, 2023

    Neuroendocrine Tumors Trial in Toronto (Sorafenib, Cyclophosphamide)

    Completed
    Has Results
    • Neuroendocrine Tumors
    • Toronto, Ontario, Canada
      Princess Margaret Hospital
    Oct 9, 2018

    Breast Cancer, Brain Metastases Trial in United States (Whole Brain Radiotherapy (WBRT), Sorafenib)

    Completed
    • Breast Cancer
    • Brain Metastases
    • Basking Ridge, New Jersey
    • +5 more
    Mar 4, 2022